GeoPharma (GORX) Posts Q2 Loss of $0.18, Wider Y/Y; Revs Lower
GeoPharma Inc. (NASDAQ: GORX) reports Q2 loss of $0.18, compared to ($0.15) in the same quarter last year. Revenue for the quarter was $3.41 million, versus $5.10 million in Q209.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- Synopsys, Inc. (SNPS) Misses Q2 EPS by 2c; Issues Confident Q3 Outlook; Guides FY12
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
